Ovarian cancer prognosis in women with endometriosis: a retrospective nationwide cohort study of 32,419 women
article
OA: green
CC0
⤵ 22 in-corpus citations
AI-generated summary
This study investigated the association between endometriosis and ovarian cancer prognosis in a nationwide cohort of 32,419 women, examining survival outcomes.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (33)
- Creating Solutions in Endometriosis: Global Collaboration through the World Endometriosis Research Foundation via openalex
- Creating Solutions in Endometriosis: Global Collaboration through the World Endometriosis Research Foundation: via openalex
- Does the Presence of Endometriosis Affect Prognosis of Ovarian Cancer? via openalex
- ENDOMETRIAL CARCINOMA OF THE OVARY, ARISING IN ENDOMETRIAL TISSUE IN THAT ORGAN via openalex
- Endometriosis and risk of ovarian and endometrial cancers in a large prospective cohort of U.S. nurses via openalex
- Endometriosis-associated Ovarian Cancer: A Distinct Clinical Entity? via openalex
- Endometriosis-associated ovarian cancer is a single entity with distinct clinicopathological characteristics via openalex
- Endometriosis-Associated Ovarian Carcinoma (EAOC): An Entity Distinct from Other Ovarian Carcinomas as Suggested by a Nested Case-Control Study via openalex
- Endometriosis is the independent prognostic factor for survival in Chinese patients with epithelial ovarian carcinoma via openalex
- Epidemiology of endometriosis: a large population‐based database study from a healthcare provider with 2 million members via openalex
- Immunology of endometriosis via openalex
- Improved clinical outcomes of patients with ovarian carcinoma arising in endometriosis via openalex
- Incidence of endometrioid and clear-cell ovarian cancer in histological proven endometriosis: the ENOCA population-based cohort study via openalex
- Incidence of Laparoscopically Confirmed Endometriosis by Demographic, Anthropometric, and Lifestyle Factors via openalex
- Increased risk for ovarian cancer and borderline ovarian tumours in subfertile women with endometriosis via openalex
- Malignant changes in endometriosis. via openalex
- Prognostic value of endometriosis in patients with stage I ovarian clear cell carcinoma: Experiences at three academic institutions via openalex
- Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis via openalex
- Role of endometriosis as a prognostic factor for post‑progression survival in ovarian clear cell carcinoma via openalex
- The association between endometriosis and gynecological cancers and breast cancer: A review of epidemiological data via openalex
- W6745521881 via openalex
- W2148084356 via openalex
- W2150678612 via openalex
- W2163315477 via openalex
- W2166310305 via openalex
- W2125681453 via openalex
- W2047119337 via openalex
- W2529730559 via openalex
- W2885738414 via openalex
- W2936024984 via openalex
- W6720400915 via openalex
- W6745224953 via openalex
- W2137074525 via openalex
Cited by (22)
- Research Progress on Endometriosis-Associated Ovarian Cancer 2026
- Endometriosis and ovarian cancer: epidemiological evidence, molecular insights, and clinical decision-making 2026
- Ovarian Cancer and Its Association with Endometriosis: A Narrative Review 2025
- Transformation maligne d’endométriome découverte dans un contexte de surinfection d’endométriome : cas clinique 2025
- Clinicopathological and prognostic outcomes of endometriosis-associated ovarian cancer 2025
- Endometriosis and autoimmunity 2025
- Endometriosis-associated ovarian cancer: a different clinical entity 2024
- Factors in malignant transformation of ovarian endometriosis: A narrative review 2024
- Evaluation of Immune Infiltrates in Ovarian Endometriosis and Endometriosis-Associated Ovarian Cancer: Relationship with Histological and Clinical Features 2023
- Additional file 1 of An analysis of clinical characteristics and prognosis of endometrioid ovarian cancer based on the SEER database and two centers in China 2023
- Correlation of clinicopathological and prognostic characteristics between endometriosis-associated and primary ovarian cancer 2023
- Pictorial essay: MRI evaluation of endometriosis-associated neoplasms 2023
- Insights from Mendelian randomization and genetic correlation analyses into the relationship between endometriosis and its comorbidities 2023
- Endometriosis: not just a benign disease 2022
- Pelvic Artificial Isolation with Ultrasound-Guided Fluid: A New Technique In Ovarian Endometriotic Cyst Transabdominal Sclerotherapy 2022
- Endometriosis-Associated Ovarian Cancer: What Are the Implications for Women with Intact Endometrioma Planning for a Future Pregnancy? A Reproductive Clinical Outlook 2022
- Prognostic markers of inflammation in endometrioid and clear cell ovarian cancer 2022
- Correlation of Clinicopathological and Prognostic Characteristics between Endometriosis-Associated and Primary Ovarian Cancer 2021
- Verlängertes Überleben bei Patientinnen mit Ovarialkarzinom und Endometriose 2021
- Endometriosis and gynaecological cancers: molecular insights behind a complex machinery 2021
- Closing the communication loop between gynecological surgeons, diagnostic imaging experts and pathologists in endometriosis: building bridges between specialties 2021
- Verlängertes Überleben bei Patientinnen mit Ovarialkarzinom und Endometriose 2021
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:21:47.975235+00:00
License: CC0
· commercial use OK